Free Trial

Privia Health Group (PRVA) Competitors

Privia Health Group logo
$25.97 -0.04 (-0.15%)
Closing price 10/22/2025 04:00 PM Eastern
Extended Trading
$25.97 0.00 (0.00%)
As of 10/22/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PRVA vs. HIMS, GH, RDNT, BTSG, SHC, OPCH, WGS, VCYT, HTFL, and GRAL

Should you be buying Privia Health Group stock or one of its competitors? The main competitors of Privia Health Group include Hims & Hers Health (HIMS), Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Option Care Health (OPCH), GeneDx (WGS), Veracyte (VCYT), Heartflow (HTFL), and GRAIL (GRAL). These companies are all part of the "healthcare" industry.

Privia Health Group vs. Its Competitors

Hims & Hers Health (NYSE:HIMS) and Privia Health Group (NASDAQ:PRVA) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, risk, valuation, profitability and institutional ownership.

Hims & Hers Health has higher revenue and earnings than Privia Health Group. Hims & Hers Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers Health$2.01B5.33$126.04M$0.8059.31
Privia Health Group$1.74B1.84$14.39M$0.11236.09

Hims & Hers Health currently has a consensus price target of $38.92, indicating a potential downside of 17.99%. Privia Health Group has a consensus price target of $28.91, indicating a potential upside of 11.32%. Given Privia Health Group's stronger consensus rating and higher probable upside, analysts clearly believe Privia Health Group is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
3 Sell rating(s)
10 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.93
Privia Health Group
1 Sell rating(s)
2 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.71

Hims & Hers Health has a net margin of 9.63% compared to Privia Health Group's net margin of 0.78%. Hims & Hers Health's return on equity of 26.26% beat Privia Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Hims & Hers Health9.63% 26.26% 13.06%
Privia Health Group 0.78%2.13%1.25%

Hims & Hers Health has a beta of 2.25, suggesting that its stock price is 125% more volatile than the S&P 500. Comparatively, Privia Health Group has a beta of 0.83, suggesting that its stock price is 17% less volatile than the S&P 500.

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 94.5% of Privia Health Group shares are held by institutional investors. 13.7% of Hims & Hers Health shares are held by company insiders. Comparatively, 10.7% of Privia Health Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Hims & Hers Health had 50 more articles in the media than Privia Health Group. MarketBeat recorded 53 mentions for Hims & Hers Health and 3 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.69 beat Hims & Hers Health's score of 0.68 indicating that Privia Health Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
18 Very Positive mention(s)
13 Positive mention(s)
14 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Privia Health Group
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Hims & Hers Health beats Privia Health Group on 10 of the 16 factors compared between the two stocks.

Get Privia Health Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRVA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PRVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PRVA vs. The Competition

MetricPrivia Health GroupMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$3.19B$2.25B$6.17B$10.67B
Dividend YieldN/AN/A5.72%4.86%
P/E Ratio236.1137.1629.0927.13
Price / Sales1.8411.31584.28126.20
Price / Cash144.1560.1037.1261.42
Price / Book4.5612.0812.246.43
Net Income$14.39M-$64.36M$3.33B$276.63M
7 Day Performance1.72%-3.81%-0.79%-0.77%
1 Month Performance10.60%-0.73%5.27%0.68%
1 Year Performance48.32%28.91%69.02%32.03%

Privia Health Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PRVA
Privia Health Group
2.9953 of 5 stars
$25.97
-0.2%
$28.91
+11.3%
+47.3%$3.19B$1.74B236.111,140
HIMS
Hims & Hers Health
2.6607 of 5 stars
$51.40
+3.3%
$38.92
-24.3%
+101.1%$11.25B$1.48B64.251,637Trending News
Analyst Forecast
Insider Trade
Analyst Revision
GH
Guardant Health
3.9349 of 5 stars
$70.20
+7.2%
$65.86
-6.2%
+234.3%$8.16B$739.02M-20.962,021Upcoming Earnings
Analyst Forecast
Gap Up
RDNT
RadNet
3.4159 of 5 stars
$78.44
+2.0%
$76.80
-2.1%
+19.3%$5.92B$1.91B-392.1811,021News Coverage
Positive News
BTSG
BrightSpring Health Services
2.5911 of 5 stars
$30.47
+2.5%
$32.13
+5.4%
+104.5%$5.27B$12.57B98.2935,000Trending News
Earnings Report
Analyst Forecast
Insider Trade
SHC
Sotera Health
2.4152 of 5 stars
$16.71
+3.4%
$17.20
+2.9%
+8.2%$4.59B$1.10B208.903,000
OPCH
Option Care Health
4.7677 of 5 stars
$28.38
+2.2%
$35.10
+23.7%
-6.8%$4.51B$5.00B22.708,088Positive News
Upcoming Earnings
WGS
GeneDx
2.9117 of 5 stars
$127.03
+5.0%
$109.78
-13.6%
+109.4%$3.47B$362.32M2,540.601,200Upcoming Earnings
Analyst Forecast
VCYT
Veracyte
4.0047 of 5 stars
$36.65
+2.3%
$40.90
+11.6%
+6.6%$2.82B$445.76M111.06790Analyst Forecast
HTFL
Heartflow
N/A$35.05
+3.8%
$36.60
+4.4%
N/A$2.82B$148.54M0.00699News Coverage
GRAL
GRAIL
0.6708 of 5 stars
$91.85
+17.8%
$56.67
-38.3%
+458.9%$2.81B$125.60M-7.011,360Analyst Forecast
High Trading Volume

Related Companies and Tools


This page (NASDAQ:PRVA) was last updated on 10/23/2025 by MarketBeat.com Staff
From Our Partners